Oral Formulation Roadmap from Early Drug Discovery to Development - Rilegato

Rilegato

ISBN 10: 1118907337 ISBN 13: 9781118907337

Casa editrice: John Wiley & Sons Inc, 2017

Riassunto

Detailing formulation approaches by stage of discovery to early development, this book gives a “playbook” of practical and efficient strategies to formulate drug candidates with the least chance of failing in clinical development.

• Comes from contributing authors with experience developing formulations on the frontlines of the pharmaceutical industry
• Focuses on pre (or non-) clinical and early stage development, the phases where most compounds are used in drug research
• Features case studies to illustrate practical challenges and solutions in formulation selection
• Covers regulatory filing, drug metabolism and physical and chemical properties, toxicology formulation, biopharmaceutics classification system (BCS), screening approaches, early stage clinical formulation development, and outsourcing

Su questo libro

Informazioni sull?autore

Elizabeth Kwong, PhD, retired from Merck & Co., Inc. in 2011, after 23 years of service. She then established her own company, Kwong Eureka Solutions, as a consultant for small start-up companies and specialty drug products. Dr. Kwong is on the Board of Directors for the Canadian Society of Pharmaceutical Scientists and is also an adjunct professor in the Department of Pharmaceutics at the University of Montreal and Department of Chemistry at Concordia University. More recently, Dr. Kwong also co-founded a start-up company, Giiant Pharma, working on delivering a colon specific PDEIV Inhibitor prodrug for the treatment of ulcerative colitis.

Dalla quarta di copertina

Many of the challenges facing drug discovery and development stem from a failure to properly identify formulations that translate from preclinical to clinical phases. Further, a lack of collaboration and proper integration between formulation and discovery scientists contribute significantly to most failures in the clinic. Lastly, the regulatory requirements for formulations also increase the timelines and costs of bringing a drug candidate forward.

Written to address these many challenges and issues, this book describes and explains the key factors that help determine the types of formulation needed throughout the stages of drug discovery. Detailing formulation approaches by stage of discovery to early development, Oral Formulation Roadmap from Early Drug Discovery to Development gives a “playbook” of practical and efficient strategies to formulate drug candidates with the least chance of failing in clinical development.

A key reference for practicing pharmaceutical scientists, this book provides a valuable resource that:

• Comes from contributing authors with experience developing formulations on the frontlines of the pharmaceutical industry

• Focuses on pre (or non-) clinical and early stage development, the phases where most compounds are used in drug research

• Features case studies to illustrate practical challenges and solutions

• Covers regulatory filing, drug metabolism and properties, biopharmaceutics classification system (BCS), screening approaches, toxicology studies, clinical formulation development, and outsourcing

Dal risvolto di copertina interno

Many of the challenges facing drug discovery and development stem from a failure to properly identify formulations that translate from preclinical to clinical phases. Further, a lack of collaboration and proper integration between formulation and discovery scientists contribute significantly to most failures in the clinic. Lastly, the regulatory requirements for formulations also increase the timelines and costs of bringing a drug candidate forward.
 
Written to address these many challenges and issues, this book describes and explains the key factors that help determine the types of formulation needed throughout the stages of drug discovery. Detailing formulation approaches by stage of discovery to early development, Oral Formulation Roadmap from Early Drug Discovery to Development gives a "playbook" of practical and efficient strategies to formulate drug candidates with the least chance of failing in clinical development.
 
A key reference for practicing pharmaceutical scientists, this book provides a valuable resource that:
 
* Comes from contributing authors with experience developing formulations on the frontlines of the pharmaceutical industry
 
* Focuses on pre (or non-) clinical and early stage development, the phases where most compounds are used in drug research
 
* Features case studies to illustrate practical challenges and solutions * Covers regulatory filing, drug metabolism and properties, biopharmaceutics classification system (BCS), screening approaches, toxicology studies, clinical formulation development, and outsourcing

Dettagli dell'edizione

• Editore: John Wiley & Sons Inc
• Data di pubblicazione: 2017
• Lingua: Inglese
• ISBN 10: 1118907337
• ISBN 13: 9781118907337
• Rilegatura: Copertina rigida
• Numero edizione: 1
• Numero di pagine: 252
• Redattore: Kwong Elizabeth
• Contatto del produttore: WROX; https://www.wiley.com/en-us; ; 111 River Street; Hoboken; NJ; 7030; U.S.A.
• Persona responsabile: non disponibile